Processa Pharmaceuticals, Inc. (PCSA) stock
PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.86+0.02 (+1.09%)
Close on Nov 13, 2026Market cap $5.20MP/E –Yield –
Processa Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Processa Pharmaceuticals's profit margin for the twelve months ending Dec 31, 2016 was -38341.3%. For fiscal 2016 it was -38341.3%, against -2957.2% the year before. The highest annual figure on record is -982.0% in fiscal 2013.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | -38341.3% | −35384.1 |
| FY2015 | Dec 31, 2015 | -2957.2% | +1263.5 |
| FY2014 | Dec 31, 2014 | -4220.7% | −3238.7 |
| FY2013 | Dec 31, 2013 | -982.0% | +288.1 |
| FY2012 | Dec 31, 2012 | -1270.2% | – |
See a number that looks wrong?